Angiosarcoma of the breast (AB) is a rare entity: its overall incidence is estimated at between 0.002% and 0.005% per year. Some potential risk factors have been described, mainly previous irradiation of the breast. We report the experience of the European Institute of Oncology with this unusual disease from January 1996 to January 2006: sixteen patients with angiosarcoma, 9 (56%) of whom had primary AB and 7 (44%), secondary AB, are discussed
Angiosarcoma of the breast : the experience of the European Institute of Oncology and a review of the literature / A. Luini, G. Gatti, J. Diaz, E. Botteri, E. Oliveira, R.C. Sahium de Almeida, P. Veronesi, M. Intra, G. Pagani, P. Naninato, G. Viale. - In: BREAST CANCER RESEARCH AND TREATMENT. - ISSN 0167-6806. - 105:1(2007 Sep), pp. 81-85.
Angiosarcoma of the breast : the experience of the European Institute of Oncology and a review of the literature
P. Veronesi;G. VialeUltimo
2007
Abstract
Angiosarcoma of the breast (AB) is a rare entity: its overall incidence is estimated at between 0.002% and 0.005% per year. Some potential risk factors have been described, mainly previous irradiation of the breast. We report the experience of the European Institute of Oncology with this unusual disease from January 1996 to January 2006: sixteen patients with angiosarcoma, 9 (56%) of whom had primary AB and 7 (44%), secondary AB, are discussedPubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.